MARC record from Internet Archive

LEADER: 07408cam 2200901Ia 4500
001 ocn458558729
003 OCoLC
005 20200509022830.0
008 091023s2009 ne ob 001 0 eng d
006 m o d
007 cr mnu---unuuu
010 $a 2009929356
040 $aGW5XE$beng$epn$cGW5XE$dN$T$dOCLCQ$dEBLCP$dOSU$dOCLCQ$dCUS$dUAB$dCOO$dUX0$dE7B$dOCLCQ$dNLGGC$dOCLCQ$dOCLCF$dOHS$dBEDGE$dOCLCQ$dOCLCO$dA7U$dYDXCP$dDEBSZ$dOCLCQ$dTXI$dOCLCQ$dESU$dOCLCQ$dVT2$dOCLCO$dOCLCA$dCEF$dU3W$dWYU$dYOU$dCNTRU$dOCLCO$dUKAHL$dOCLCQ$dZHM$dERF$dUHL$dOCLCQ$dOCLCA$dOCLCQ
019 $a430538815$a465701812$a514170713$a646817465$a664235587$a756717325$a767188629$a1005821832$a1067035222$a1087439047$a1097273350$a1110730562$a1112554865$a1113170265
020 $a9789048122455$q(e-isbn)
020 $a9048122457$q(e-isbn)
020 $z9789048122448
020 $z9048122449
024 7 $a10.1007/978-90-481-2245-5$2doi
035 $a(OCoLC)458558729$z(OCoLC)430538815$z(OCoLC)465701812$z(OCoLC)514170713$z(OCoLC)646817465$z(OCoLC)664235587$z(OCoLC)756717325$z(OCoLC)767188629$z(OCoLC)1005821832$z(OCoLC)1067035222$z(OCoLC)1087439047$z(OCoLC)1097273350$z(OCoLC)1110730562$z(OCoLC)1112554865$z(OCoLC)1113170265
050 4 $aQH585.4$b.C455 2009eb
060 4 $aQU 475
072 7 $aMED$x106000$2bisacsh
072 7 $aMBGR$2bicssc
082 04 $a616/.0277$222
245 00 $aCell line development /$cedited by Mohamed Al-Rubeai.
260 $aDordrecht ;$aNew York :$bSpringer,$c℗♭2009.
300 $a1 online resource (viii, 253 pages)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
347 $atext file$bPDF$2rda
490 1 $aCell engineering ;$vv. 6
504 $aIncludes bibliographical references and index.
588 0 $aPrint version record.
520 $aMammalian cell lines command an effective monopoly for the production of therapeutic proteins that require post-translational modifications. This unique advantage outweighs the costs associated with mammalian cell culture, which are far grater in terms of development time and manufacturing when compared to microbial culture. The development of cell lines has undergone several advances over the years, essentially to meet the requirement to cut the time and costs associated with using such a complex hosts as production platforms. This book provides a comprehensive guide to the methodology involved in the development of cell lines and the cell engineering approach that can be employed to enhance productivity, improve cell function, glycosylation and secretion and control apoptosis. It presents an overall picture of the current topics central to expression engineering including such topics as epigenetics and the use of technologies to overcome positional dependent inactivation, the use of promoter and enhancer sequences for expression of various transgenes, site directed engineering of defined chromosomal sites, and examination of the role of eukaryotic nucleus as the controller of expression of genes that are introduced for production of a desired product. It includes a review of selection methods for high producers and an application developed by a major biopharmaceutical industry to expedite the cell line development process. The potential of cell engineering approch to enhance cell lines through the manipulation of single genes that play important roles in key metabolic and regulatory pathways is also explored throughout.
505 0 $aUse of MAR Elements to Increase the Production of Recombinant Proteins -- Expression Engineering -- The IE2 Promoter/Enhancer from Mouse CMV -- Defeating Randomness -- Targeted Integration as a Boost for Biotechnology -- Importance of Genetic Environment for Recombinant Gene Expression -- Expression Vector Engineering for Recombinant Protein Production -- Cell Xpress™ Applications in Development and Characterization of Biopharmaceutical Recombinant Protein Producing Cell Lines -- Selection Methods for High-Producing Mammalian Cell Lines -- Engineering Mammalian Cells for Recombinant Monoclonal Antibody Production -- Engineering Cell Function by RNA Interference -- Apoptosis and Autophagy Cell Engineering -- Glycoengineering and Modeling of Protein N-Glycosylation -- Engineering the Secretory Pathway in Mammalian Cells.
650 0 $aCell lines.
650 2 $aCell Culture Techniques.
650 2 $aCell Line.
650 7 $aMEDICAL$xResearch.$2bisacsh
650 7 $aSciences de la vie.$2eclas
650 7 $aBiome decine.$2eclas
650 7 $aCell lines.$2fast$0(OCoLC)fst00850191
655 4 $aElectronic books.
700 1 $aAl-Rubeai, Mohamed,$d1948-
776 08 $iPrint version:$tCell line development.$dDordrecht ; New York : Springer Verlag, ℗♭2009$z9789048122448$w(DLC) 2009929356$w(OCoLC)310400323
830 0 $aCell engineering ;$vv. 6.
856 40 $3ProQuest Ebook Central$uhttp://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=478148
856 40 $3ProQuest Ebook Central$uhttp://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=4419530
856 40 $3ebrary$uhttp://site.ebrary.com/id/10323232
856 40 $3EBSCOhost$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=292053
856 40 $3Scholars Portal$uhttp://books.scholarsportal.info/viewdoc.html?id=/ebooks/ebooks2/springer/2011-03-04/1/9789048122455
856 40 $3SpringerLink$uhttps://doi.org/10.1007/978-90-481-2245-5
856 40 $3SpringerLink$uhttp://link.springer.com/10.1007/978-90-481-2245-5
856 40 $3SpringerLink$uhttps://link.springer.com/openurl?genre=book&isbn=978-90-481-2244-8
856 40 $3VLeBooks$uhttp://www.vlebooks.com/vleweb/product/openreader?id=none&isbn=9789048122455
856 40 $uhttps://0-link-springer-com.pugwash.lib.warwick.ac.uk/10.1007/978-90-481-2245-5$zConnect to Springer e-book
856 40 $uhttp://www.library.yorku.ca/e/resolver/id/1927833$zAn electronic book accessible through the World Wide Web; click for information
856 4 $3Cover$uhttp://swbplus.bsz-bw.de/bsz430807406cov.htm$v20150512142325
856 4 $3Scholars Portal Books$uhttp://www.library.yorku.ca/e/resolver/id/1927832
856 40 $uhttp://dx.doi.org/10.1007/978-90-481-2245-5$xproxy
856 $uhttps://discover.gcu.ac.uk/discovery/openurl?institution=44GLCU_INST&vid=44GLCU_INST:44GLCU_VU2&?u.ignore_date_coverage=true&rft.mms_id=991002487198403836$p5372097850003836$xStGlGCU
856 40 $uhttps://www.dawsonera.com/guard/protected/dawson.jsp?name=https://idp.shu.ac.uk/shibboleth&dest=http://www.dawsonera.com/abstract/9789048122455$zGo to eBook via Dawsonera
856 $uhttps://shu-primo.hosted.exlibrisgroup.com/openurl/44SHU/44SHU_VU1?u.ignore_date_coverage=true&rft.mms_id=9914721802501$p5338932670002501
938 $aAskews and Holts Library Services$bASKH$nAH26902730
938 $aProQuest Ebook Central$bEBLB$nEBL4419530
938 $aProQuest Ebook Central$bEBLB$nEBL478148
938 $aebrary$bEBRY$nebr10323232
938 $aEBSCOhost$bEBSC$n292053
938 $aYBP Library Services$bYANK$n3096280
029 1 $aAU@$b000048657144
029 1 $aDEBSZ$b430807406
029 1 $aNLGGC$b321859537
029 1 $aNLGGC$b322555353
029 1 $aNZ1$b13120122
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 380 OTHER HOLDINGS